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Abstract
Background: TLR8 assists in antiviral approach by producing Type 1 INF via MyD88 dependent IRF7 pathway.
However, over expression of INFα/β molecule poses threat by developing tolerance in chronic infection cases and
enhancing inflammatory response. Here we report a bi-specific siRNA based complex which differentially activates
and silences the TLR8 and MYD88 respectively in a negatively regulated fashion.
Results: Outer membrane vesicle from Escherichia coli used for siRNA delivery was observed more efficient when
attached with invasive protein Ail along with OmpA (P < 0.001) in HEK293-TLR8 cell line. siRNA complexed with p19
protein was efficient in activating TLR8, confirmed by the increment of INFβ molecules (P < 0.001) in HEK293-TLR8
compared to its counterpart. Fusion of lipid bilayer of endosomal compartment was significant at pH 4.5 when
fusogenic peptides (diINF-7) were incubated in membrane vesicle, thus facilitating the escape of siRNA complex to
the host cytoplasm in order to silence MyD88 transcript (P < 0.001).
Conclusions: We investigated the activation of TLR8 by bi-specific si-RNA for the production of INFβ. In the same
setting we showed that bi-specific si-RNA was able to silence MyD88 transcript in a delayed manner. For the cases
of auto immune disease and inflammation where over activation of endosomal TLRs poses serious threat, bi specific
siRNA could be used as negative feedback controlled system.
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Background
Endosomal TLR7/8 are specialized for the detection of
ssRNAs [1] and are component of innate immune re-
sponse [2, 3]. TLR7/8 are activated by whole RNA from
viruses and/or certain synthetic single-stranded oligoribo-
nucleotides (ORNs) as well double-stranded small inter-
fering RNA sequences [4, 5] among which, ssRNA strand
of minimum 19 bp with high GU or U rich content are
found to be more potent as TLR7/8 agonist [5]. Thus,
TLR7/8 agonists are promising enough to be used as
vaccine adjuvents [6] and in passive immunotherapy
approaches [7].
The differential functionality of IFN Type I (IFN-I) pro-
duced after activation of TLR7/8 have been studied against
broad range of viral infections. Interferon-α inducible pro-
tein 6 (IFI6) can inhibit the Hepatitis C virus (HCV) entry
by inhibiting EGFR mediated CD81/CLDN1 interactions
[8]. Similarly, in HBV infection, IFNα mediates suppression
of enhancer region En I, which are critical for HBV gene
expression and replication [9–11]. Also, in case of HIV-1
infection, the IFNα upregulated CD317(tetherin) in-
hibits the release of newly assembled virions [12, 13]
whereas, tripartite-motif-containing 5α (TRIM5α) re-
stricts the incoming HIV-1 capsid, which is also up
regulated by Type 1 IFNs [14]. The role of IFN-I may
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always not be true as mentioned in above instances as in
chronic cases like HIV/SIV infection. In these chronic cases,
the pattern of IFN mediated antiviral response is dependent
upon the amount and duration of IFN molecules admin-
istration [15]. The continued IFN treatment can induce
IFN-I desensitization and decrease antiviral gene ex-
pression, enabling infection with increased SIV reser-
voir size and accelerated CD4 T-cell loss [15]. Even
continued IFN production via TLR7/8 results in de-
creased Interferon Stimulating Gene (ISG) expression
like cGAS, APOBEC3G, MX2, tetherin and TRIM5α in
SIV infected models [15].
Hence, it seems crucial to delay the expression pattern
of IFN in order to avoid the tolerance in those infected
systems. This study focuses on the administration of
siRNA, as agonist for TLR7/8, which initiates ISG expres-
sion formerly and simultaneously would silence the MyD88
transcript. The silencing happens only after escaping
from the endosome, so as to halt the signaling between
the TLR7/8 and ISG expression in MyD88-IRAK1-TRAF6-
IRF7 cascade [16, 17]. Thus, activation of TLR7/8 inside en-
dosome and the silencing of MyD88 mRNA in cytoplasm
in a delayed timing is the main objective of this study.
Methods
Bacterial strain, plasmids and cell line
Escherichia coli (F- mcrA Δ (mrr-hsdRMS-mcrBC)
φ80lacZΔM15 ΔlacX74 nupG recA1 araD139 Δ (ara-
leu)7697 galE15 galK16 rpsL (StrR) endA1 λ−) was
the model system used for the cloning and expression of
the plasmids (Additional file 1) as well for the production
of outer membrane vesicle for siRNA delivery. siRNA
(Additional file 1) was prepared as described elsewhere
[18]. In order to study the protein translocation, green
fluorescence protein (gfp) was used as reporter system [19].
The pSB1C3 containing E. coli was induced using 20 μM
arabinose and consecutively cells were washed and 1 mM
IPTG was added to repress the pBAD derived promoter in
pSB1C3 before fluorescence measurement. The relative
fluorescence levels present in the different cellular fractions
were quantified using Qubit®2.0 Fluorometer (485-nm exci-
tation/535-nm emission). The human embryonic kidney
cell line (HEK293) was stably transfected with pcDNA-
TLR8-YFP (which was a kind gift from Doug Golenbock
(Addgene plasmid # 13024) and was cultured in Dulbecco’s
modified Eagle’s medium (DMEM), containing 4.5 g/l glu-
cose and supplemented with 10 % (v/v) fetal bovine serum
along with 50 U/ml penicillin, 50 mg/ml streptomycin,
200 μg/ml Neomycin and 2 mM L-glutamine.
Outer membrane vesicle preparation and invasion assay
E coli overnight culture having 0.8 OD600 were sub-
jected for centrifugation at 6,000 × g and supernatant
was filtered through Durapore® sterilizing-grade hydrophilic
polyvinylidene fluoride (PVDF) membranes (Merck
Millipore). The OMVs were collected after ultracentrifuga-
tion at 100,000 × g at 4 °C (Optima™ XE, Beckman coulter)
for 3 h and finally resuspended in PBS [20]. To determine
the endocytosis of OMVs in HEK293-TLR8 cell line, the
Ail [21] along with OmpA [22] were expressed in E coli
using pSB1C3. The invasive activity was determined on
the basis of Ail.OmpA mediated endocytosis and escape
from the late endosome provoked by fusogenic peptide,
diINF-7. The invasion assay was done for 60 minutes
allowing co-incubation of purified OMVs and HEK293-
TLR8 cell. The incubation was followed by washing of
cells to remove attached OMVs on surface and cell prepar-
ation for further analysis.
p19.siRNA complex dissociation
Dissociation of siRNA from the p19.siRNA complexes was
observed by gel electrophoresis. The outer membrane
vesicle containing pSB1C3 construct for p19.siRNA.torA
were subjected to lysis in GES reagent (100 mM EDTA
pH8.0, 5 M guanidinium thiocyanate, and 1 % (w/v) N-
Lauroylsarcosine salt of sodium) then were vortexed for
20s to allow the homogenization. The lysed content were
incubated in the pH conditions ranging from 7.5 to 5.0 for
30 min at room temperature then each sample were elec-
trophoresed on 20 % polyacrylamide gel. The composition
for each pH were as follows: pH = 7.5 (PBS buffer (7.5),
pH = 7.0 (200 mM dibasic sodium phosphate and 100 mM
citric acid), pH = 6.5 (200 mM monosodium phosphate
and 200 mM disodium hydrogen phosphate), pH = 6.0
(100 mM citric acid and 100 mM sodium citrate), pH = 5.5
(20 mM sodium acetate buffer, 100 mM sodium chloride),
and pH = 5.0 (200 mM sodium cacodylate and 200 mM
hydrogen chloride).
Cytotoxicity assay for outer membrane derived vesicles
HEK293-TLR8 cells were seeded on a 96-well plate at a cell
density of 1 × 104 cells/mL and was grown for 24 h in
DMEM with 10 % FBS. Cells were then co cultured with all
available OMVs (Additional file 1) complexes per well
(50 μl OMV [OD600 0.8]/well). Fifty microliter of CytoTox-
Glo™ Cytotoxicity Assay Reagent (Promega, USA) per well
(12.5 μl for a 384-well plate) of HEK293-TLR8 was also
added and luminescence was measured after incubating for
15 minutes at room temperature. After that, 50 μl of lysis
reagent was added to all wells (12.5 μl for a 384-well plate),
mixed and incubated at room temperature for 15 minutes.
Then again, luminescence was measured and the viable cell
luminescence was calculated as manufacturer’s instruction.
Enzyme Link Immunosorbent Assay for INFβ
quantification
ELISA for IFN-β was done in every 2 hours using different
confluence state of HEK-TLR8 (70 %, 80 %, 90 %) each after
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60 minutes of OMVs invasion assay using Human IFN-β
ELISA kit (Tocris Bioscience, MN, USA) and was performed
according to manufactures instruction.
MyD88 gene silencing in vitro
In vitro gene silencing efficacy of siRNA complexes was
evaluated with MyD88 gene expressing HEK293-TLR8
cells. We performed the reverse transcription-polymerase
chain reaction (RT-PCR) to analyze the MyD88 silencing
efficacy of siRNA complexes. RT-PCR was performed using
the same volume of cultured cell in triplicate but of differ-
ent confluence state (70 %, 80 %, 90 %), and 60 minutes be-
fore RT-PCR, the cell line was transfected with OMV
aliquot of same concentration (50 μl OMV [OD600 0.8]/
well) and this process was repeated until 48 hr of cell
growth cycle. Every time, the cells were harvested, lysed,
and total RNAs were extracted using TRIzol® Reagent
(Thermo-Fisher, USA) and reverse transcription was per-
formed using one step RT-PCR kit (QIAGEN, Germany)
according to the manufacturer’s protocol in triplicates. The
PCR primers (Additional file 1) were synthesized and puri-
fied by IDT (California, USA). The quantitative analysis
was done using Rotor-Gene 6000 (Corbett Life Science,
Valencia, CA, USA).
Statistical analyses
Results were analyzed using GraphPad Prism 6.0 software
(GraphPad Software Inc, La Jolla, CA, USA) and the results
were analyzed by Student’s t test which is parametric
and p value < 0.001 was considered as significant result,
unless described otherwise.
Results
Transport of torA-fusion proteins to periplasm of
Escherichia coli
In order to transport the siRNA, we needed siRNA to be
packed in outer membrane vesicle (OMVs), thus we de-
vised torA fusion system which would efficiently transport
the proteins from cytoplasm to periplasm of E.coli. The
relative light unit for OMVs quantitatively increased in first
8 hr from cells containing torA fused gfp in pSB1C3 back-
bone (P < 0.001) but the vesicle without torA fusion back-
bone failed to generate significant fluorescence. In the
absence of periplasmic signal peptide construct torA, gfp
wasn’t transported up to periplasm from cytoplasm in
order to emit florescence (Fig. 1a). In this way, all the
siRNA and accessory proteins were packed in OMVs and
were ready for transfection in HEK293-TLR8 cell line.
Ail mediated endocytosis of outer membrane vesicle in
HEK293-TLR8 cell line
After efficient packaging of TLR8 agonist and MyD88 si-
lencing components in OMV, we asked how efficient this
system is in entering the HEK293-TLR8. Delivery of cargo
vesicle inside host cell was found to be increased signifi-
cantly with the use of invasive protein Ail from Yersinia
pestis. The fluorometric analysis done pre/post OMV
invasion in confluent (90 %) HEK-293-TLR8 cell line
confirmed the increament in intracellular fluorescence
for the OMVs from pSB1C3.Ail.diINF-7.gfp.torA. Fur-
ther, there was >2 fold increments observed in RFU
unit on the OMVs from pSB1C3 which had 464 bp of
OmpA attached at the NH2 terminal of Ail in its 60 minutes
assay (Fig. 1c). The co-incubation of purified OMVs and
HEK293-TLR8 cell followed by washing of cells and ob-
servation of fluorometric output in every 10 minutes
showed the increment up to 30-40 % (P < 0.001) of
maximum RFU value within 20 minutes of the assay,
suggesting a rapid invasion of OMVs attached with
OmpA (pSB1C3.Ail.diINF.gfp.OmpA.torA) but not for
OMVs from pSB1C3.Ail.diINF.gfp.torA. The latter had
30-40 % of maximum RLU after 30 minutes, suggesting
slower HEK293-TLR8 invasion and endosomal escape
in absence of OmpA (Fig. 1c). Treatment with colchicine
had shown little effect in invasion as shown by reduced
(2–3 fold for 8 μg/ml) fluorometric value of pSB1C3.Ail.-
diINF-7.gfp.OmpA.torA and pSB1C3.Ail.diINF-7.gfp.torA,
suggesting the invasion in fact is mediated by cytoskeletal
movements (data not shown).
Fusogenic activity of diINF-7 in outer membrane vesicles
In the line of our hypothesis, pH dependent fusion of lipid
bilayer was achieved in E. coli derived OMVs containing
diINF-7 peptide fragment. The OMV cargo which included
the agonist for TLR8 should be cut open in order to free
the components so it can act as ligand for TLR8 and as well
escape the endosome so as to arrive in cytoplasm. The con-
struct pSB1C3.diINF-7.lux.torA in an IPTG repressible pro-
moter pBAD were transfected in E.coli, and OMV vesicles
were isolated in order to measure the luminescence value
at different pH buffer. The vesicle broke down at 4.5 pH
thus providing highest RLU value (P < 0.001), irrespective
of presence of Ail/OmpA (Fig. 1b).
Escape from endosomal cargo to cytoplasm
Since we knew in vitro that silencing and agonist cargo
could be escaped from OMVs at pH 4.5 but could it be
used to escape endosome as well. The answer was yes,
and to demonstrate the phenomenon we used saporin so as
to mark the escape of endosomal cargo to cytoplasm. The
cell death was used as a indicator for endosomal escape
since saporin is a ribosomal inactivating protein. The
OMVs derived from construct pSB1C3.Ail.diINF-7.OmpA.
saporin.torA was able to decrease the cell survival percent-
age significantly after 16 hr of co culture. After 48 hr of
co culture, the cell growth completely stopped and cell
mortality was near 100 %. Construct lacking at least
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any of saporin/diINF-7/Ail/OmpA/torA was unable to
initiate cell death (Fig. 2a).
siRNA binding protein complex p19 for efficient
transportation
To avoid siRNA degradation and efficient delivery, we used
p19 siRNA Binding Protein (19 kDa) from the Carnation
Italian Ringspot Virus (CIRV) plant which binds siRNAs
with nanomolar affinity. After confirmation of cargo
transport up to cytoplasm, we deployed OMVs equipped
with 21ntd. siRNA derived from the pSB1C3.Ail.diINF-
7.OmpA.p19-siRNA.torA construct. The silencing of MyD88
as well as IFNβ was observed after 2 hr of co culture,
and also there was a significant difference in the activity in
presence and absence of p19 specifically between 10–
12 hr of co culture (Fig. 2b). This showed that, siRNA
can be packed in with p19 which would transport and
save it from nucleases in host cytoplasm.
Fig. 1 a Transport into outer membrane vesicle: In the presence of periplasmic signal (torA) gfp transportation to periplasm was significant (*P < 0.001)
compared to construct which lacked torA signal (n = 10). b Fusion of lipid bilayer by diINF-7: The fusogenic activity was observed in presence of diINF-7
along with torA signal at pH 5.0(*P < 0.001) and 4.5(**P < 0.001). Also, the fusogenic activity was affected by presence or absence of torA signal
peptide at pH 5.0(°P < 0.001) and 4.5(°°P < 0.001) but was independent of presence or absence of Ail/OmpA. c TLR8-HEK293 invasion
assay: In presence of OmpA signal, the invasion was rapid as well at 30 minutes of assay the fluorometric output increased significantly
(**P < 0.001). Values show the mean ± S.D (n = 10). The statistical analysis was performed by unpaired Student’s t test (*P < 0.001)
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Fig. 2 (See legend on next page.)
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pH dependent siRNA dissociation from transporter
complex p19
We confirmed that siRNA could be detached from p19
complex in a pH dependent manner so p19 couldn’t
interfere in siRNA’s functional activity. The OMVs (de-
rived from pSB1C3.Ail.diINF-7.p19-siRNA.torA) treated
with decreasing pH conditions and simultaneous ex-
tracts from the buffer showed high intensity at low pH
in polyacrylamide gel. The polyacrylamide gel assay
showed the optimum dissociation of siRNA-p19 com-
plex at pH 5.0 with maximum relative band intensity
compared to pH 7.0, 6.5, 6.0, 5.5 (Fig. 2c). The result
showed that, at increasing acidic condition of endosomal
compartment, the siRNA-p19 complex might dissociate
and thus facilitate siRNA binding to TLR8 as ligand and
as well escape to cytoplasm for the formation of RISC
complex.
siRNA as ligand for TLR8 & regulator for IFNβ production
by MyD88 silencing
The IFNβ production as well as rate of silencing of
MyD88 was significant in presence of siRNA (P < 0.001).
There was a fluctuating plane for the IFNβ production
in presence of siRNA construct providing the efficient
silencing of mRNA in a delayed timing (Fig. 2b). The
transcript of MyD88 diminished by >4 folds when the
OMVs construct along with siRNA complex was incu-
bated with HEK293-TLR8 (Fig. 2b). As expected the
OMVs construct lacking at least any of Ail/diINF-7/
siRNA/torA from pSB1C3.Ail.diINF-7.OmpA.siRNA.torA
didn’t show any decrement on the MyD88 mRNA. IFNβ
production decreased as much as by 28 % from the con-
struct siRNA.diINF-7 compared to siRNA alone, due to the
silencing the adaptor protein MyD88’s transcript (Fig. 2b).
Discussion
We developed a mechanism which combines siRNA
production, delivery, attachment to target cell, endocyto-
sis, activation of TLR-8 and final escape from endosomal
compartment to silence MyD88 transcript. The result of
this study showed that, bi specific siRNA can be used
differentially to activate TLR8 as ligand and silence
MyD88 transcript, thus making a temporary stop at the
over activation of TLR8 which can otherwise evokes in-
flammatory cascade. TLRs are important component of
innate immune system which works for virus inhibition,
DC maturation to antigen uptake for CD4+ T helper cell
differentiation based on the activation of different cyto-
kines expressed under influence of ISGs [22–24]. Cyto-
kines induce positive feedback in immune system but if
left unchecked can cause immunopathology like Crohn’s
and inflammatory bowel disease, which are results of un-
balanced immune response [25]. Duration of TLR medi-
ated response is controlled by different factors such as,
number of TLR expressed, availability of ligands and
competitive features of ligand. Termination of TLR sig-
nals by regulation of receptor imminent molecules are
described for different proteins; however, components
that restrict MyD88 transcript are poorly defined specif-
ically in case where initially the same component would
activate IRF7 cascade [26–29].
In case of HIV-1 infection, TLR8 recognizes HIV-1
ssRNA during HIV-1 infection, where HIV-1 uses TLR8
signaling to activate NF-Κb for production of Tat-Rev
mRNA via MyD88 dependent cascade [30] in dentritic
cell but in the same setting when MyD88 was silenced,
the replication of HIV-1 was aborted thus suggesting
NF-κB activation by TLR8 triggering is an absolute pre-
requisite for HIV-1 transcription initiation by RNAPII.
Thus, using bi-siRNA as described in our work, the ini-
tial antiviral cytokines could be expressed and later by
silencing MyD88 in differential manner; the transcrip-
tion of viral mRNA could be halted.
Since, DC infection is primarily involved in HIV-1
transmission via sexual act, inhibitors of MyD88 signal-
ing cascade might represent as new antiretroviral drug
although escalating the innate system via inflammatory
cytokines in first place is immense due to its anti viral
properties.
Constitutive MyD88 dependent TLR signals are proved
to be advantageous, inflammation devoid signals [31];
however, these also could trigger inflammation, thus ques-
tion on how to differentiate between inflammatory and
homeostatic TLR signals remains. Proteins like IRAK-M,
SIGIRR and suppressor of cytokine signaling (SOCS-1)
can restrict TLR homeostatic signals from becoming in-
flammatory by restricting the duration and intensity of
TLR signals [32,33]. MyD88 is an crucial signal transducer
in Helicobactor pylori infected epithelial cells of human
[34] which can induce proinflammatory cytokines includ-
ing IL-6, IL-10, IL-1β and IL-12 in a TLR dependent man-
ner [35,36]. It was reported that, RNA interference by
(See figure on previous page.)
Fig. 2 a Cell death as marker of transport to cytoplasm: The cell viability decreased in presence of saporin which peaked in 48 h (**P < 0.001).
The construct lacking any of Ail (°P < 0.001), diINF-7 (°P < 0.001), torA (°P < 0.001) and OmpA (°P < 0.001) failed to decrease the cell viability
significantly in presence of saporin construct. b The presence of p19 was essential for binding of siRNA (°P < 0.001). The addition or deletion of
p19 (°P < 0.001)/siRNA (*P < 0.001)/diINF-7 (•P < 0.001) had significant effect in INFβ production as well MyD88 transcript abundance. c pH
dependent dissociation was observed and siRNA was free from p19 complex (*P < 0.001). Values show the mean ± S.D (n = 10). The statistical
analysis was performed by unpaired Student’s t test (*P < 0.001)
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miR-155 is able to negatively regulated the release of
proinflammatory cytokines in H. pylori infected systems
[37,38]. We show here that, siRNA exerts critical nega-
tive regulatory role thus lowering the IFNβ production.
Consistent with the hypothesis, OMVs construct contain-
ing siRNA had decreased INFβ production, dependent
upon the OMVs concentration thus providing a temporary
stopover in TLR signaling (Fig. 2b).
In cardiac cells, MyD88 proteins are ubiquioustly
expressed in cytoplasm but only after the signaling
triggered by viral ssRNA, rapid redistribution of cyto-
plasmic MyD88 is seen in endoplasmic compartment
[39] suggesting a time interval between recognition of
ssRNA and MyD88 recruitment. Also, in another study,
expression of TLR8 was significantly increased in case of
ulcerative colitis (350 folds) and Crohn’s disease (45 folds)
thus suggesting role of inflammatory cytokines like TNFα
in inflammatory bowel disease (IBD) [40] which could be
fatal and in these clinical cases, if temporary halt is to be
made then partial inhibition of MyD88 is needed. Thus,
initial activation of anti viral components and later inhibit-
ing the inflammatory process may be useful in patients
with inflammatory disease who are also infected with
virus. The delivery of siRNA using OMVs could pave a
novel way for future drug delivery options though the sta-
bility of siRNA remains a hurdle as well. Usage of MyD88
silencing can have negative impact on the activation of
other TLRs beside TLR-8, which could pose a limitation in
this approach. Interestingly, since we have used human
embryonic kidney cell line, the apical TLR signal might
preferentially induce homeostatic signal in this cell type,
but in case of dendritic cell, it could have triggered inflam-
mation. So the nature of activation is dependent in cell
type as well. Another question raised by this study is how
to determine the exact value of TLR8 activation and
MyD88 transcriptional deactivation as well as its kinetics
which would answer, for how long the activation and si-
lencing would be beneficial to certain diseased state. This
issue could only be addressed, when the experiment is car-
ried out in vivo with subjected diseased state, where the
dose dependent outcome could be monitored, which is
also a limitation of this study.
This study supports the notion that MyD88 signals are
to be maintained at threshold for proper homeostasis in
innate system. However, above that threshold, innate in-
flammatory responses may be evoked which may result
in chronic inflammation. But, also, insufficient MyD88
signalling would result in impaired situations for host
survival, including, antimicrobial peptide secretion and
tissue repair from acute inflammatory response. The
finding of this study should be elaborated in future for
distinguishing the needed degree of activation of TLR
and deactivation of MyD88 thus avoiding inflammatory
responses.
Conclusion
The study devises a mechanism to pack and deliver en-
dogenously expressed bi specific siRNA which could
be used as TLR8 agonist as well as to silence MyD88
transcript. This mechanism could be used in case of
inflammatory disease with viral infection where a negative
component is needed to avoid inflammation and in the
same time innate system should be activated to avoid for-
eign intrusion. Also, the system is interesting enough to
be used in primary cell lines to establish new set of data
on silencing and activating TLR8.
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